Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

IBUPROFEN SODIUM

IBUPROFEN SODIUM

Standard Dose
EQ 200MG BASE
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview IBUPROFEN SODIUM is listed in Drugs@FDA under application 206581 (ANDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient IBUPROFEN SODIUM Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor PERRIGO R AND D Submission history Latest submission status date: 2016-02-19 00:00:00.

Structured Monograph

Clinical summary

Approval overview IBUPROFEN SODIUM is listed in Drugs@FDA under application 206581 (ANDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient IBUPROFEN SODIUM Form and strength TABLET;ORAL - EQ 200MG BASE Sponsor PERRIGO R AND D Submission history Latest submission status date: 2016-02-19 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.